Free Trial

OraSure Technologies (OSUR) Competitors

OraSure Technologies logo
$2.55 -0.25 (-8.93%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$2.61 +0.06 (+2.31%)
As of 05/21/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OSUR vs. CERS, UTMD, ANIK, COO, WST, ALGN, MMSI, ICUI, HAE, and XRAY

Should you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry.

OraSure Technologies vs.

Cerus (NASDAQ:CERS) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Cerus received 17 more outperform votes than OraSure Technologies when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 68.87% of users gave OraSure Technologies an outperform vote.

CompanyUnderperformOutperform
CerusOutperform Votes
570
72.34%
Underperform Votes
218
27.66%
OraSure TechnologiesOutperform Votes
553
68.87%
Underperform Votes
250
31.13%

Cerus has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.

OraSure Technologies has a net margin of 5.07% compared to Cerus' net margin of -11.60%. OraSure Technologies' return on equity of 3.55% beat Cerus' return on equity.

Company Net Margins Return on Equity Return on Assets
Cerus-11.60% -40.55% -11.12%
OraSure Technologies 5.07%3.55%3.23%

OraSure Technologies has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerus$185.14M1.29-$37.49M-$0.10-12.50
OraSure Technologies$161.63M1.18$53.65M-$0.42-6.07

78.4% of Cerus shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 3.4% of Cerus shares are owned by insiders. Comparatively, 3.9% of OraSure Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, OraSure Technologies had 11 more articles in the media than Cerus. MarketBeat recorded 13 mentions for OraSure Technologies and 2 mentions for Cerus. Cerus' average media sentiment score of 0.84 beat OraSure Technologies' score of 0.57 indicating that Cerus is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cerus
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OraSure Technologies
5 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cerus presently has a consensus price target of $3.50, indicating a potential upside of 180.00%. OraSure Technologies has a consensus price target of $3.00, indicating a potential upside of 17.65%. Given Cerus' stronger consensus rating and higher possible upside, equities analysts plainly believe Cerus is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cerus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
OraSure Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Cerus beats OraSure Technologies on 10 of the 18 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSUR vs. The Competition

MetricOraSure TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$190.74M$4.49B$5.37B$8.39B
Dividend YieldN/A43.63%5.22%4.10%
P/E Ratio17.0029.4326.8419.71
Price / Sales1.1867.72392.34117.39
Price / Cash2.8951.0838.2534.62
Price / Book0.446.236.794.50
Net Income$53.65M$68.16M$3.23B$248.18M
7 Day Performance3.66%-0.19%1.53%0.20%
1 Month Performance-13.85%19.19%10.05%12.37%
1 Year Performance-49.50%21.47%16.71%7.04%

OraSure Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSUR
OraSure Technologies
4.0302 of 5 stars
$2.55
-8.9%
$3.00
+17.6%
-48.0%$190.74M$161.63M17.00840Analyst Forecast
CERS
Cerus
2.8923 of 5 stars
$1.35
+4.7%
$3.50
+159.3%
-32.4%$258.07M$185.14M-12.27290Positive News
Gap Up
UTMD
Utah Medical Products
2.1588 of 5 stars
$54.02
+0.8%
N/A-22.4%$177.29M$39.27M13.68180Positive News
Dividend Announcement
ANIK
Anika Therapeutics
4.1355 of 5 stars
$11.85
+1.8%
$21.33
+80.0%
-54.5%$169.94M$119.91M-1.78300Gap Up
COO
Cooper Companies
3.1303 of 5 stars
$84.44
+2.6%
$110.25
+30.6%
-18.0%$16.89B$3.93B43.3014,000Positive News
Analyst Upgrade
WST
West Pharmaceutical Services
4.5697 of 5 stars
$219.20
+2.9%
$332.50
+51.7%
-38.0%$15.75B$2.90B32.7710,700Trending News
Analyst Revision
ALGN
Align Technology
4.7819 of 5 stars
$189.00
+3.9%
$241.25
+27.6%
-34.9%$13.84B$3.98B33.6923,200Positive News
MMSI
Merit Medical Systems
4.1455 of 5 stars
$98.73
+3.0%
$107.78
+9.2%
+17.2%$5.83B$1.39B48.406,850Trending News
Analyst Forecast
Insider Trade
Analyst Revision
ICUI
ICU Medical
4.7589 of 5 stars
$144.34
+4.4%
$192.67
+33.5%
+27.3%$3.55B$2.38B-31.5814,500Analyst Upgrade
Insider Trade
Gap Up
HAE
Haemonetics
4.3176 of 5 stars
$70.23
+3.0%
$97.89
+39.4%
-28.2%$3.53B$1.36B27.652,820Analyst Forecast
Gap Up
XRAY
DENTSPLY SIRONA
4.9515 of 5 stars
$16.75
+5.9%
$20.36
+21.6%
-43.9%$3.34B$3.72B-8.0915,000

Related Companies and Tools


This page (NASDAQ:OSUR) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners